前列腺癌患者教育材料的可读性:使用可读性指标进行全面评估
Julian Risch1, Konrad Hügelmann1, Leonhard Buck1
1Department of Urology, University Hospital of Schleswig-Holstein, Kiel, Germany.
Urologia internationalis
|October 13, 2025
概括
德国前列腺癌患者教育材料太难让非专业人士理解. 可读性得分表明阅读水平远高于推的七年级,阻碍了理解和知情决策.
科学领域:
- 在瘤学瘤学.
- 医学沟通 医学沟通
- 卫生识字 卫生识字
背景情况:
- 患者教育材料 (PEMs) 对于患者了解病情和治疗选择至关重要.
- 前列腺癌护理中的复杂医学术语可能会阻碍患者的理解和知情决策.
- 评估前列腺癌PEM的可读性至关重要,以确保它们符合普通观众的标准.
研究的目的:
- 评估德国可用的前列腺癌患者教育材料 (PEMs) 的可读性.
- 为了确定这些材料是否符合欧盟推的非专业人士理解的门.
- 确定需要改善前列腺癌信息的清晰度和可访问性的领域.
主要方法:
- 分析了一系列标准化前列腺癌PEMs,包括来自德国主要癌症组织的手术同意表和患者手册.
- 使用多个已建立的指标来评估可读性:弗莱什阅读易度得分 (FRES),弗莱什-金凯德等级水平 (FKGL),枪支雾得分 (GFS),SMOG指数,科尔曼-利乌指数 (CLI) 和自动可读性指数 (ARI).
- 根据欧盟的建议,对非专业人士的可读性标准定义为FRES≥70和年级级度量≤7.
主要成果:
- 前列腺癌PEMs,包括同意表格和小册子,未能满足欧盟的可读性标准的 Lai观众.
- 同意表格的Flesch阅读易度得分 (FRES) 中位数为25.9,患者手册的Flesch阅读易度得分为23.2,表明阅读水平远低于推值.
- 所有评估的年级水平指标 (FKGL,GFS,SMOG,CLI,ARI) 超过了推的七年级水平,这意味着对理解的重大障碍.
结论:
- 德国的前列腺癌患者教育材料对公众来说不够易读.
- 建议实施自动化可读性工具,并坚持标准化基准 (FRES ≥70,等级水平 ≤7) 以提高清晰度.
- 未来的研究应该将患者的反与可读性指标相结合,以评估这些材料的实际理解和可用性.
相关概念视频
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Health Literacy
5.2K
Health literacy is an individual's or a community's capacity to comprehend, receive, read, and use relevant healthcare information and services. The World Health Organization (WHO, 2018) defines health literacy as the cognitive and social skills that determine the ability of individuals to gain access to, understand, and use information in ways that promote and maintain good health. As a result, the WHO helps individuals manage long-term health concerns, participate in preventative...
5.2K
Cancer Prevention
7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.6K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.4K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K


